Assignee
CELYNTRA THERAPEUTICS SA
BE·5 granted patents·5 pending applications·6 citations·filing 2021–2023
Top patents by PatentIndex Score
10 records- 0188US12270044B2CRISPR systems with engineered dual guide nucleic acidsCELYNTRA THERAPEUTICS SA·Filed 2023·Granted Apr 8, 2025·3 cites·27 claims
- 0288US12270043B2Compositions and methods for targeting, editing, or modifying genesCELYNTRA THERAPEUTICS SA·Filed 2023·Granted Apr 8, 2025·3 cites·19 claims
- 0372US12319932B2Compositions and methods for targeting, editing, or modifying genesCELYNTRA THERAPEUTICS SA·Filed 2022·Granted Jun 3, 2025·0 cites·12 claims
- 0467US12529076B2CRISPR systems with engineered dual guide nucleic acidsCELYNTRA THERAPEUTICS SA·Filed 2021·Granted Jan 20, 2026·0 cites·30 claims
- 0564US2026022404A1Compositions and methods for genome editingCELYNTRA THERAPEUTICS SA·Filed 2023·Application pending·0 cites
- 0664US2026009009A1Modified nucleasesCELYNTRA THERAPEUTICS SA·Filed 2022·Application pending·0 cites
- 0761US2025197811A1Compositions and methods for generating cells with reduced immunogenicityCELYNTRA THERAPEUTICS SA·Filed 2023·Application pending·0 cites
- 0859US12571006B2Constructs and uses thereof for efficient and specific genome editingCELYNTRA THERAPEUTICS SA·Filed 2021·Granted Mar 10, 2026·0 cites·20 claims
- 0958US2025179481A1Compositions and methods for targeting, editing, or modifying genesCELYNTRA THERAPEUTICS SA·Filed 2022·Application pending·0 cites
- 1054US2025223558A1Large scale manufacturing of ipsc derived hsc and progenyCELYNTRA THERAPEUTICS SA·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CELYNTRA THERAPEUTICS SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →